Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Solesence (SLSN) EBT (2016 - 2026)

Solesence filings provide 17 years of EBT readings, the most recent being -$766000.0 for Q1 2026.

  • On a quarterly basis, EBT fell 1057.5% to -$766000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $1.0 million, a 72.14% decrease, with the full-year FY2025 number at $1.9 million, down 58.25% from a year prior.
  • EBT hit -$766000.0 in Q1 2026 for Solesence, down from -$154000.0 in the prior quarter.
  • In the past five years, EBT ranged from a high of $3.1 million in Q2 2025 to a low of -$2.1 million in Q4 2023.
  • Median EBT over the past 5 years was -$154000.0 (2025), compared with a mean of -$86117.6.
  • The widest YoY moves for EBT: up 566.0% in 2023, down 1969.35% in 2023.
  • Solesence's EBT stood at -$2.0 million in 2022, then decreased by 5.99% to -$2.1 million in 2023, then skyrocketed by 84.4% to -$331000.0 in 2024, then soared by 53.47% to -$154000.0 in 2025, then tumbled by 397.4% to -$766000.0 in 2026.
  • The last three reported values for EBT were -$766000.0 (Q1 2026), -$154000.0 (Q4 2025), and -$1.1 million (Q3 2025) per Business Quant data.